Physician profile

Thomas F Scully

Urology · Saint Louis, MO

NPI 1285692608

$6,974.49

in general payments reported to CMS, 2019-2025

42 companies · $1,435 in 2025

The $1,435 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).

See the full distribution for Urology

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$4,688.71

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Boston Scientific Corporation $897.42 2019-2025 Rezum Generator, Spaceoar Vue System - 10ml, Moses 550 Dfl
Teleflex LLC $647.06 2021-2025 Urolift, Barrigel
Endo Pharmaceuticals INC. $577.95 2021-2024 Xiaflex, Aveed, Edex
Calyxo, INC. $524.51 2024-2025 Cvac Aspiration System
Astellas Pharma US INC $450.08 2019-2023 Myrbetriq
Medtronic, INC. $449.66 2023-2024 Interstim
Axonics, INC. $413.60 2022-2023 Bulkamid
Progenics Pharmaceuticals, INC. $289.50 2022-2023 Pylarify
Myriad Genetic Laboratories, INC. $245.77 2024-2025 Prolaris
Antares Pharma, INC. $245.03 2021-2024 Xyosted, Tlando, Nocdurna
Cook Medical LLC $188.02 2024-2025 Cook
C. R. Bard, INC. & Subsidiaries $186.46 2024-2025 Bard Urinary Drainage Bag, Magic3 Go Intermittent Urinary Catheter
Janssen Biotech, INC. $160.60 2019
Urogen Pharma, INC. $160.12 2024-2025
Urovant Sciences INC $128.49 2021-2022
Show all 42 companies
CompanyGeneral paymentsYearsTop products
Sumitomo Pharma America, INC. $127.80 2023-2024 Gemtesa
Ferring Pharmaceuticals INC. $124.99 2025 Adstiladrin
Janssen Scientific Affairs, LLC $124.98 2025 Erleada
Becton, Dickinson and Company $120.52 2024 Bard Urinary Drainage Bag
Srs Medical Systems, INC. $118.26 2021-2023 Urocuff
Aytu Biopharma, INC. $101.30 2019
Pfizer INC. $64.22 2019-2023
Abbvie INC. $63.37 2023-2024 Botox, Lupron Depot
Convatec INC. $61.87 2023-2024
Allergan, INC. $58.13 2019-2021
Bayer Healthcare Pharmaceuticals INC. $56.11 2020-2023
Olympus America INC. $42.81 2023 Itind System
Verity Pharmaceuticals INC. $40.78 2022-2024 Trelstar
Baxter Healthcare $36.01 2023 Perclot
Tolmar, INC. $34.00 2023
Acerus Pharmaceuticals Corporation $32.02 2021-2022
Travere Therapeutics, INC. $24.70 2020
Astrazeneca Pharmaceuticals LP $22.03 2023 Lynparza
Tolmar Pharmaceuticals, INC. $19.97 2019
Abbott Laboratories $19.75 2025 Eterna
Laborie Medical Technologies Corp. $18.39 2025
Myovant Sciences INC. $18.25 2021
Ge Healthcare $17.88 2019
Rochester Medical Corporation $17.70 2022
180 Medical, INC. $16.25 2023 Gentlecath Glide
Dentsply Ih INC. $14.90 2019
Cumberland Pharmaceuticals, INC. $13.23 2021

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Thomas F Scully

$6,974.49

in general payments reported 2019-2025

Years
2019-2025
Top company
Boston Scientific Corporation
Context
The $1,435 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).

https://glasscript.com/doctor/13253/thomas-f-scully

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.